Evolution of carfilzomib dose and schedule in patients with multiple myeloma: a historical overview.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Evolution of carfilzomib dose and schedule in patients with multiple myeloma: a historical overview.

Jakubowiak AJ. Evolution of carfilzomib dose and schedule in patients with multiple myeloma: a historical overview. Cancer Treat Rev. 2014 Jul; 40(6):781-90.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Clinical Trials as Topic
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Approval
Humans
Infusions, Intravenous
Multiple Myeloma
Oligopeptides
United States

authors with profiles

Andrzej Jakubowiak